The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association between guideline-adherent imaging and overall survival following second-line targeted therapy for metastatic renal cell carcinoma.
Peggy L. Lin
Consultant or Advisory Role - employee of Analysis Group, Inc, which has received consulting fees from Novartis
Research Funding - employee of Analysis Group, Inc, which has received consulting fees from Novartis
Sumanta Kumar Pal
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Eric Jonasch
Consultant or Advisory Role - Novartis
Research Funding - Novartis
James E. Signorovitch
Consultant or Advisory Role - employee of Analysis Group, Inc, which has received consulting fees from Novartis
Research Funding - employee of Analysis Group, Inc, which has received consulting fees from Novartis
Zhimei Liu
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Kenneth W. Culver
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Jeffrey A. Scott
Employment or Leadership Position - Cardinal Health
Stock Ownership - Cardinal Health
Nicholas J. Vogelzang
Employment or Leadership Position - US Oncology
Consultant or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bayer; PAREXEL International